Most people are familiar with A, B, AB and O blood types, but there are hundreds of additional blood group “antigens” on red blood cells – substances that can trigger the body’s immune response – that differ from person to person. Each year, up to 16 deaths reported to the Federal Drug Administration are attributed to mismatches in red blood cell antigens that are not related to differences in A, B and O blood groups. Currently, no method is available that can determine all blood antigens. But as whole genome sequencing becomes routine for patients, it may be possible to modernize therapy by identifying both rare donors and at-risk recipients before blood transfusions.
In a new study, investigators from Brigham and Women’s Hospital and Harvard Medical School, as well as from the New York Blood Center have leveraged the MedSeq Project – the first randomized trial of whole genome sequencing in healthy adults – to develop and validate a computer program that can comprehensively and cost-effectively determine differences in individuals’ blood types with more than 99 percent accuracy. The team’s results are reported in The Lancet Haematology.
“Blood transfusion complications are common in patients needing chronic transfusion, but with current technology it is not cost effective to do blood typing for all antigens,” said first author William Lane, MD, PhD, director of Clinical Laboratory Informatics and assistant director of the Tissue Typing Laboratory in the BWH Department of Pathology. “But the algorithm we have developed can be applied to type everyone for all relevant blood groups at a low cost once sequencing is obtained.”
Blood transfusions are one of the most common procedures in medicine with more than 11 million units of blood transfused in the U.S. each year. Complications from blood transfusions can be life-threatening. When the body encounters foreign antigens on the donor cells, it can stimulate production of antibodies that can destroy the transfused donor cells. From birth, people have antibodies unique to their ABO blood type, but other antibodies against specific blood antigens can be stimulated during pregnancy from exposure to fetal cells or exposure to donor cells when receiving multiple blood transfusions.
“This approach has the potential to be one of the first routine clinical uses of genomics for medical care for patients needing blood transfusion,” said co-first author Connie M. Westhoff, PhD, at the New York Blood Center. “It could prevent serious or even fatal complications because once patients are sensitized they have a life-long risk of hemolytic transfusion reactions if blood transfusion is needed in an emergency.”
Today, most testing for blood donors and patients include only ABO and Rh matching, but more than 300 red blood cell antigens and 33 platelet antigens are known. To create a way to cost-effectively type many people for these antigens, Lane teamed up with scientists directing the MedSeq Project and experts in blood group genetics at the New York Blood Center to build a database and develop a computer software algorithm, known as bloodTyper, that could rapidly and accurately predict an individual’s blood group antigen profile from genomic sequences. Lane, Westhoff and colleagues validated the software by comparing it to traditional, and more labor-intensive, methods. bloodTyper was more than 99 percent accurate when typing from the MedSeq Project participants’ genomes. Lane notes that this work would not have been possible without access to samples from the MedSeq Project, and close collaboration with MedSeq’s principal investigator, Robert Green, MD, MPH, and co-investigator, Heidi Rehm, PhD.
“This report demonstrates a previously unanticipated use case and benefit that will accrue as whole genome sequencing become a routine part of medical care,” said Green, one of the senior authors on the study, director of the Genomes2People Research Program at BWH and professor of medicine at Harvard Medical School. “Genome sequencing can now identify potential transfusion recipients who need rare blood types and the individuals who can safely provide them.”
The Latest on: Whole genome sequencing
via Google News
The Latest on: Whole genome sequencing
- Fungal Whole Genome de novo Sequencing on December 19, 2018 at 8:06 pm
CD Genomics provides fungal whole genome sequencing with the PacBio Sequel system to offer more insights into genetic structure and functions. We are best in the knowledge, practise, and experience. P... […]
- Digital Genome Market to Surpass US$ 17.3 Billion Threshold by 2026 on December 19, 2018 at 6:24 am
The service is intended to be used for precise medicine for cancer. In December 2017, PerkinElmer collaborated with Neuromuscular Disease Foundation for launching Whole Genome Sequencing research cond... […]
- Noncoding Genome Mutations Contribute To Autism Risk on December 15, 2018 at 9:38 am
A whole-genome sequencing study of nearly 2,000 families has implicated mutations in promoter regions of the genome – regions that precede the start of a gene – in autism spectrum disorder. The study ... […]
- Autism risk factors identified in ‘dark matter’ of human genome on December 14, 2018 at 12:17 pm
Published December 14 in the journal Science, the study is the largest to date for whole-genome sequencing in autism. It included 1,902 families comprised of both biological parents, a child affected ... […]
- Next Generation Sequencing Market Is Driven By Rising Development Of Efficient And Rapid Genomic Sequencing Till 2025: Grand View Research, Inc. on December 13, 2018 at 6:53 am
This allows oncologists to genetic information about cancer cells and tumors. As per, technology, the market can be bifurcated into targeted sequencing analysis, whole genome sequencing (WGS), and who... […]
- I Got My Whole Genome Sequenced. Here’s What I Learned. on December 11, 2018 at 9:52 am
Dante Labs sent me their Full DNA whole genome sequencing package, and I went through a roller-coaster of feelings: I was excited to know every secret of my DNA, but I was afraid of getting to know my ... […]
- 100,000 Genomes Project hits landmark sequencing goal on December 10, 2018 at 9:18 am
The UK reached its goal of sequencing 100,000 patient genomes last week. The 100,000 Genomes Project, led by Genomics England in partnership with NHS England, was launched in 2012 with the aim of appl... […]
- How next-generation sequencing will impact your food safety program on December 10, 2018 at 2:01 am
In fact, two-thirds of European countries are using whole-genome sequencing (WGS), one of several applications of NGS, for national surveillance of human pathogens. So, what is NGS? In short, next-gen... […]
- 100,000 Genomes Project reaches sequencing goal on December 7, 2018 at 9:01 am
Genomics England worked with NHS England to create 13 NHS Genomic Medicine Centres (GMCs) to support the project, a state-of-the-art sequencing centre, and an automated analytics platform to return wh... […]
via Bing News